Publications

List of Publications

Bulondo, F., Babensee, J.E., Optimization of Interleukin-10 Incorporation for Dendritic cells Embedded in Poly(ethylene glycol) Hydrogels, J. Biomed. Mater. Res., 1-20, (2024).

Beskid, N.M., Kolewole, E., Coronel, M.M., Nguyen, B., Evavold, B., Garcia, A.J., Babensee, J.E., IL-10-Functionalized Hydrogels Support Immunosuppressive Dendritic Cell Phenotype and Function, ACS Biomaterials Science and Engineering, 8: 4341–4353 (2022).

Srinivasan, S., Babensee, J.E., Dendritic cells support a proliferative antigen-specific T-cell response in the presence of poly(lactic-co-glycolic acid), J Biomed Mater Res, 109: 2269–2279 (2021).

Thomas, A.M., Beskid, N.M., Blanchfield, J.L., Rosado, A.M., García, A.J. Evavold, B.D., Babensee, J.E., Localized hydrogel delivery of dendritic cells for attenuation of multiple sclerosis in a murine model, J Biomed Mat Res, 109: 1247–1255 (2021).

Srinivasan, S., Babensee, J.E., Controlled Delivery of Immunomodulators from a Biomaterial Scaffold Niche to Induce a Tolerogenic Phenotype in Human Dendritic Cells, ACS Biomaterials Science and Engineering, 6: 4062-4076 (2020).

Thomas, A.M., Dong, Y., Beskid, N.M., García, A.J., Adams, A.B., Babensee, J.E., Brief Exposure to Hyperglycemia Activates Dendritic Cells in vitro and in vivo, J. Cell. Physiol. 235: 5120-5129 (2020).

Hotaling, N.A., Tang, L., Irvine, D.J., Babensee, J.E., Biomaterial Strategies for Immunomodulation, Annual Review of Biomedical Engineering, 17:13.1–13.33 (2015).

Park, J., Gerber, M.H., Babensee, J.E., Phenotype And Polarization Of Autologous T Cells By Biomaterial-Treated Dendritic Cells, J. Biomed. Mater. Res., 103A: 170–184 (2015).

Hotaling N., Cummings, R.D., Ratner, D., Babensee, J.E., Presentation Modality of Engineered Glycoconjugates Modulates Dendritic Cell Phenotype, Biomaterial Sciences, 2(10): 1426 – 1439 (2014).

Hotaling N., Cummings, R.D., Ratner, D., Babensee, J.E., Molecular Factors in Dendritic Cell Responses to Adsorbed Glycoconjugates, Biomaterials, 35: 5862–5874(2014).

Park, J., Babensee, J.E., Differential Functional Effects Of Biomaterials On Dendritic Cell Maturation, Acta Biomaterialia, 8:3606–3617 (2012).

Kou PM, Pallassana N, Cunningham B, Joy A, Kohn J, Babensee JE. Predicting biomaterial property-dendritic cell phenotype relationships from the multivariate analysis of responses to polymethacrylates. Biomaterials,33:1699-1713 (2012).

Kou, P.M., Schwartz, Z., Boyan, B.D., Babensee, J.E., Dendritic cell responses to surface properties of clinical titanium implants, Acta Biomaterialia, 7:1354-1363 (2011).

Cornelius, R.M., Shankar, S.P., Brash, J.L., Babensee, J.E., Immunoblot Analysis Of proteins Associated With Self-Assembled Monolayer Surfaces Of Defined Chemistries. J. Biomed. Mater. Res., 98A:7–18 (2011).

Kou PM, Babensee JE, Macrophage and dendritic cell phenotypic diversity in the context of biomaterials, J. Biomed. Mater. Res., 96A:239–260 (2011).

Rogers, T., Babensee, J.E., The Role of Integrins in the Recognition and Response of Dendritic Cells to Biomaterials, Biomaterials,32:1270-1279 (2011).

Norton LW, Park J, Babensee JE, “Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection,” J Control Release. 146(3):341-8, 2010.

Bridges, A.W., Whitmire, R.E., Singh, N., Templeman, K.E., Babensee, J.E., Lyon, L.A., García, A.J., Chronic Inflammatory Responses to Microgel-Based Implant Coatings, J. Biomed. Mater. Res., 94A: 252–258 (2010).

Kou PM, Babensee JE, “Validation of a high-throughput methodology to assess the effects of biomaterials on dendritic cell phenotype,” Acta Biomater., 6, 2621-2630, 2010.

Rogers TH, Babensee JE, “Altered adherent leukocyte profile on biomaterials in Toll-like receptor 4 deficient mice,” Biomaterials, 31, 594-601, 2010.​

Shankar SP, Petrie TA, Garcia AJ, Babensee JE, “Dendritic cell responses to self-assembled monolayers of defined chemistries,” J. Biomed. Mater. Res., 92A, 1487-1499, 2010.

Shankar SP, Chen II, Keselowsky BG, Garcia AJ, Babensee JE, “Profiles of carbohydrate ligands associated with adsorbed proteins on self-assembled monolayers of defined chemistries,” J. Biomed. Mater. Res., 92A, 1329-1342, 2010.

Shankar SP, Babensee JE, “Comparative characterization of cultures of primary human macrophages or dendritic cells relevant to biomaterial studies,” J. Biomed. Mater. Res., 92A, 791-800, 2010.
​
Bridges AW, Singh N, Burns KL, Babensee JE, Andrew Lyon L, Garcia AJ, “Reduced acute inflammatory responses to microgel conformal coatings,” Biomaterials, 29, 4605-4615, 2008.
​
Babensee JE, “Interaction of dendritic cells with biomaterials,” Semin. Immunol., 20, 101-108, 2008.
​
Sefton MV, Babensee JE, Woodhouse KA, “Innate and adaptive immune responses in tissue engineering,” Semin. Immunol., 20, 83-85, 2008.

Rose SL, Babensee JE, “Smooth muscle cell phenotype alters co-cultured endothelial cell response to biomaterial-pretreated leukocytes,” J. Biomed. Mater. Res., 84A, 661-671, 2008.
​
Rose SL, Babensee JE, “Complimentary endothelial cell/smooth muscle cell co-culture systems with alternate smooth muscle cell phenotypes,” Annals of Biomedical Engineering, 35, 1382-1390, 2007.
​
Keselowsky BG, Bridges AW, Burns KL, et al., “Role of plasma fibronectin in the foreign body response to biomaterials,” Biomaterials, 28, 3626-3631, 2007.

Yoshida M, Mata J, Babensee JE, “Effect of poly(lactic-co-glycolic acid) contact on maturation of murine bone-marrow derived dendritic cells,” J. Biomed. Mater. Res., 80A, 7-12, 2007.

Yoshida M, Babensee JE, “Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation,” J. Biomed. Mater. Res., 79A, 393-408, 2006.
​
Yoshida M, Babensee JE, “Molecular aspects of microparticle phagocytosis by dendritic cells,” J. of Biomaterials Science-Polymer Edition, 17, 893-907, 2006.
​
Talsma S, Babensee JE, Murthy N, Williams IR, “Development and in vitro validation of a targeted delivery vehicle for DNA vaccines,” J. Controlled Release, 112, 271-279, 2006. (two senior authors JEB and IRW contributed equally)

Babensee JE, Paranjpe A, “Differential levels of dendritic cell maturation on different biomaterials used in combination products,” J. Biomed. Mater Res., 74A, 503-510, 2005.
​
Bennewitz N, Babensee JE, “The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen,” Biomaterials, 26, 2991-2999, 2005
​
Rose SL, Babensee JE, “Procoagulant phenotype of endothelial cells after coculture with biomaterial-treated blood cells,” J. Biomed. Mater Res., 72A, 269-278, 2005.
​
Yoshida M, Babensee JE, “Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells,” J. Biomed. Mater Res., 71A, 45-54, 2004.
​
Matzelle, MM, Babensee JE, “Humoral immune responses to model antigen co-delivered with biomaterials used in tissue engineering,” Biomaterials, 25, 295-304, 2004.
​
Babensee JE, Yoshida M, Stein M, et al, “Role of biomaterial component of tissue-engineered constructs on immune responses,” Cell Transplantation, 12, 159-159, 2003.
​
Lester EA, Babensee JE, “Proinflammatory phenotype of endothelial cells after coculture with biomaterial-treated blood cells,” J. Biomed. Mater Res., 64A, 397-410, 2003.
​
Babensee JE, Stein MM, Moore, LK, “Interconnections between inflammatory and immune responses in tissue engineering, “Reparative Medicine: Growing Tissues And Organs, 961, 360-363, 2002.
​
Babensee JE, McIntire LV, Mikos AG, “Growth factor delivery for tissue engineering,” Pharmaceutical Research, 17, 497-504, 2000.
​
Babensee JE, Sefton MV, “Viability of HEMA-MMA microencapsulated model hepatoma cells in rats and the host response,” Tissue Engineering, 6, 165-182, 2000.
​
Sefton MV, May MH, Lahooti S, et al., “Making microencapsulation work: conformal coating, immobilization gels and in vivo performance,” J. of Controlled Release, 65, 173-186, 2000.
​
Babensee JE, Sefton MV, “Polyacrylates,” Cell Encapsulation Technology And Therapeutics, 173-180, 1999.
​
Ding ZM, Babensee JE, Simon SI, et al., “Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration,” J. of Immunology, 163, 5029-5038, 1999.
​
Babensee JE, Anderson JM, McIntire, LV, et al., “Host response to tissue engineered devices,” Advanced Drug Delivery Reviews, 33, 111-139, 1998.
​
Babensee JE, Cornelius RM, Brash JL, et al., “Immunoblot analysis of proteins associated with HEMA-MMA microcapsules: Human serum proteins in vitro and rat proteins following implantation,” Biomaterials, 19, 839,849, 1998.
​
Sefton MV, Hwang JR, Babensee JE, “Selected aspects of the microencapsulation of mammalian cells in HEMA-MMA,” Bioartificial Organs, 831, 260-270, 1997.
​
Babensee JE, Sodhi, RNS, Sefton MV, “X-ray photoelectron spectroscopy (XPS) surface analysis of HEMA-MMA microcapsules,” J. of Biomaterials Science-Polymer Edition, 8, 655-665, 1997.
​
Uludag H, Babensee JE, Roberts T, et al., “Controlled-release of dopamine, insulin and other agents from microencapsulated cells,” J. of Controlled Release, 24, 3-11, 1993.
​
Babensee JE, Deboni U, Sefton MV, “Morphological assessment of hepatoma-cells (HEPG2) microencapsulated in a HEMA-MMA copolymer with and without Matrigel,” J. Biomed. Mater Res., 26, 1401-1418, 1992.